137 related articles for article (PubMed ID: 38934515)
1. Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial.
Pompili E; Baldassarre M; Iannone G; Tedesco G; Nardelli S; Piano S; Alessandria C; Neri S; Foschi FG; Levantesi F; Caraceni P; Bernardi M; Zaccherini G;
Liver Int; 2024 Jun; ():. PubMed ID: 38934515
[TBL] [Abstract][Full Text] [Related]
2. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.
Caraceni P; Riggio O; Angeli P; Alessandria C; Neri S; Foschi FG; Levantesi F; Airoldi A; Boccia S; Svegliati-Baroni G; Fagiuoli S; Romanelli RG; Cozzolongo R; Di Marco V; Sangiovanni V; Morisco F; Toniutto P; Tortora A; De Marco R; Angelico M; Cacciola I; Elia G; Federico A; Massironi S; Guarisco R; Galioto A; Ballardini G; Rendina M; Nardelli S; Piano S; Elia C; Prestianni L; Cappa FM; Cesarini L; Simone L; Pasquale C; Cavallin M; Andrealli A; Fidone F; Ruggeri M; Roncadori A; Baldassarre M; Tufoni M; Zaccherini G; Bernardi M;
Lancet; 2018 Jun; 391(10138):2417-2429. PubMed ID: 29861076
[TBL] [Abstract][Full Text] [Related]
3. ALBUMIN VERSUS STANDARD MEDICAL TREATMENT IN BRAZILIAN PUBLIC AND PRIVATE HEALTHCARE SYSTEMS.
Terra C; Viayna E; Ayzin L; Fuster C; Aceituno S; Tafla C
Arq Gastroenterol; 2023; 60(3):356-363. PubMed ID: 37792766
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of long-term albumin therapy in the treatment of decompensated cirrhosis.
Khanna D; Kar P; Sahu P
Indian J Gastroenterol; 2024 Apr; 43(2):494-504. PubMed ID: 38722510
[TBL] [Abstract][Full Text] [Related]
5. Albumin administration in patients with decompensated liver cirrhosis: a meta-analytic update.
Ashour AA; Atta MA; Sadek KW; Obaid KR; Ashour MA; Ashour A; Danjuma MI; Doi SA; ElZouki AN
Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):479-486. PubMed ID: 32976190
[TBL] [Abstract][Full Text] [Related]
6. Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites.
Di Pascoli M; Fasolato S; Piano S; Bolognesi M; Angeli P
Liver Int; 2019 Jan; 39(1):98-105. PubMed ID: 30230204
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluation of long-term albumin use in cirrhosis patients from the Mexican healthcare system perspective.
Moctezuma-Velazquez C; Castro-Narro G; Simó P; Viayna E; Aceituno S; Soler M; Torre A
Ann Hepatol; 2022; 27(2):100673. PubMed ID: 35074476
[TBL] [Abstract][Full Text] [Related]
8. Human Albumin Infusion for the Management of Liver Cirrhosis and Its Complications: An Overview of Major Findings from Meta-analyses.
Zheng X; Bai Z; Wang T; Romeiro FG; Mancuso A; Philips CA; Wong YJ; Nery FG; Qi X
Adv Ther; 2023 Apr; 40(4):1494-1529. PubMed ID: 36697778
[TBL] [Abstract][Full Text] [Related]
9. On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites.
Caraceni P; Tufoni M; Zaccherini G; Riggio O; Angeli P; Alessandria C; Neri S; Foschi FG; Levantesi F; Airoldi A; Simone L; Svegliati-Baroni G; Fagiuoli S; Laffi G; Cozzolongo R; Di Marco V; Sangiovanni V; Morisco F; Toniutto P; Gasbarrini A; De Marco R; Piano S; Nardelli S; Elia C; Roncadori A; Baldassarre M; Bernardi M;
J Hepatol; 2021 Feb; 74(2):340-349. PubMed ID: 32853747
[TBL] [Abstract][Full Text] [Related]
10. Correction and Prevention of Hyponatremia in Patients With Cirrhosis and Ascites: Post Hoc Analysis of the ANSWER Study Database.
Zaccherini G; Baldassarre M; Tufoni M; Nardelli S; Piano S; Alessandria C; Neri S; Foschi FG; Levantesi F; Bedogni G; Domenicali M; Bernardi M; Caraceni P;
Am J Gastroenterol; 2023 Jan; 118(1):168-173. PubMed ID: 36087106
[TBL] [Abstract][Full Text] [Related]
11. Midodrine reduces new-onset acute kidney injury and hyponatremia in children with cirrhosis and ascites awaiting liver transplantation: Results from an open-label RCT.
Ashritha A; Lal BB; Khanna R; Sood V; Sood AK; Alam S
J Pediatr Gastroenterol Nutr; 2024 Feb; 78(2):350-359. PubMed ID: 38374552
[TBL] [Abstract][Full Text] [Related]
12. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.
Solà E; Solé C; Simón-Talero M; Martín-Llahí M; Castellote J; Garcia-Martínez R; Moreira R; Torrens M; Márquez F; Fabrellas N; de Prada G; Huelin P; Lopez Benaiges E; Ventura M; Manríquez M; Nazar A; Ariza X; Suñé P; Graupera I; Pose E; Colmenero J; Pavesi M; Guevara M; Navasa M; Xiol X; Córdoba J; Vargas V; Ginès P
J Hepatol; 2018 Dec; 69(6):1250-1259. PubMed ID: 30138685
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte colony-stimulating factor improves survival of patients with decompensated cirrhosis: a randomized-controlled trial.
Prajapati R; Arora A; Sharma P; Bansal N; Singla V; Kumar A
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):448-455. PubMed ID: 27930386
[TBL] [Abstract][Full Text] [Related]
14. Albumin in Cirrhosis: More Than a Colloid.
Paine CH; Biggins SW; Pichler RH
Curr Treat Options Gastroenterol; 2019 Jun; 17(2):231-243. PubMed ID: 30968341
[TBL] [Abstract][Full Text] [Related]
15. Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials.
Bai Z; Wang L; Wang R; Zou M; Méndez-Sánchez N; Romeiro FG; Cheng G; Qi X
Hepatol Int; 2022 Dec; 16(6):1468-1483. PubMed ID: 36048318
[TBL] [Abstract][Full Text] [Related]
16. Long-term albumin administration in patients with cirrhosis and ascites: A meta-analysis of randomized controlled trials.
Sandi BB; Leão GS; de Mattos AA; de Mattos ÂZ
J Gastroenterol Hepatol; 2021 Mar; 36(3):609-617. PubMed ID: 32914468
[TBL] [Abstract][Full Text] [Related]
17. Role of albumin infusion in cirrhosis-associated complications.
Heybe MA; Mehta KJ
Clin Exp Med; 2024 Mar; 24(1):58. PubMed ID: 38551716
[TBL] [Abstract][Full Text] [Related]
18. A dedicated paracentesis clinic decreases healthcare utilization for serial paracenteses in decompensated cirrhosis.
Cheng YW; Sandrasegaran K; Cheng K; Shah A; Ghabril M; Berry W; Lammert C; Chalasani N; Orman ES
Abdom Radiol (NY); 2018 Aug; 43(8):2190-2197. PubMed ID: 29188319
[TBL] [Abstract][Full Text] [Related]
19. Should we incorporate long-term use of albumin for patients with decompensated cirrhosis into our daily clinical practice?
Uriz Otano J; López López S; Fernández Rodríguez C
Rev Esp Enferm Dig; 2023 Aug; 115(8):414-417. PubMed ID: 36454075
[TBL] [Abstract][Full Text] [Related]
20. Can albumin reduce the mortality of patients with cirrhosis and ascites? A meta-analysis of randomized controlled trials.
Xu T; Liu W; Huang R
Eur J Gastroenterol Hepatol; 2023 Jan; 35(1):80-88. PubMed ID: 36165067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
